Sandoz Group AG (OTCMKTS:SDZNY) Sees Significant Decrease in Short Interest

Sandoz Group AG (OTCMKTS:SDZNY) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 54,700 shares, a decrease of 85.1% from the February 13th total of 366,500 shares. Based on an average daily volume of 53,600 shares, the short-interest ratio is presently 1.0 days. Currently, 0.0% of the company’s stock are sold short.

Sandoz Group Stock Performance

SDZNY stock traded up $1.36 during midday trading on Wednesday, reaching $42.18. 32,202 shares of the company’s stock traded hands, compared to its average volume of 41,895. The firm’s fifty day moving average price is $45.35 and its 200-day moving average price is $43.95. Sandoz Group has a 52 week low of $27.79 and a 52 week high of $49.81.

Analysts Set New Price Targets

Several analysts have recently commented on SDZNY shares. BNP Paribas downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd. UBS Group lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, February 3rd.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.